Who are BioPalette's investors?

BioPalette's investors include Jafco Ventures, UTEC - The University, Eight Roads Ventures, F-Prime Capital, ARCH Venture Partners.

When was BioPalette founded?

BioPalette was founded in 2017.

Where is BioPalette headquartered?

BioPalette is headquartered in Kobe, Japan.

What industry is BioPalette in?

BioPalette operates in Biotech, Genomics, Therapeutics.

How many employees does BioPalette have?

BioPalette has 11-50 employees.

BioPalette

Genome Editing x Microbiome

Kobe, Japan · Founded 2017

Biotech

Genomics

Therapeutics

Headquarters: Kobe
Employees: 11–50
Founded: 2017
Business Model: B2B

Website: biopalette.co.jp
Last Round: Series ASep 2020
Rounds: 2

About

BioPalette is a Kobe University spinout that develops genome-edited bacteria as living medicines for microbiome-based therapeutics. Its proprietary non-cutting CRISPR base-editing technologies (Target-AID and Target-G) enable precise modification of gut microbiomes without DNA strand breaks, targeting diseases driven by microbiome dysbiosis.

Summary

BioPalette is a Biotech company based in Kobe, Japan, founded in 2017. Its most recent funding was a Series A round in Sep 2020. Investors include Jafco Ventures, UTEC - The University and Eight Roads Ventures.